UUZ-10624-26395
3 vaccinations
3 coded responses
21 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 774 / TX
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Moderna
-
2021-01-09
Registered in v-safe
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-01-10
- 2021-01-11
- 2021-01-13
- 2021-01-21
- 2021-01-29
-
2021-01-31
Dose 2 — Moderna
- 2021-02-03
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia — Feeling: FairFree text: Tingling on left sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-07
-
2021-02-14
Survey response — day 14, dose 2MedDRA: Cough, Oropharyngeal pain — Feeling: GoodFree text: Coughing, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-03-14
- 2021-05-02
- 2021-08-01
-
2021-12-09
Dose 3 — Moderna
- 2022-02-02
- 2022-06-09
-
2022-12-09
Survey response — 12 months, dose 3MedDRA: Cough, Nasal congestion, Nausea, Paranasal sinus hypersecretion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Nausea, stuffy nose, severe cough, sinus drainageMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-12
-
2022-12-12
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-01-31 | Moderna | |
| 3 | 2021-12-09 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-09 | Successful 2022-12-12 |
Completed over the phone |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Tingling on left side
Release 4 — day 14, dose 2
Symptoms: Coughing, sore throat
Release 12 — 12 months, dose 3
Symptoms: Nausea, stuffy nose, severe cough, sinus drainage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release